Cooper Companies (COO) Revenue and Net Income History
Historical revenue, operating income and net income for Cooper Companies (COO) over the last 10 years. The current TTM revenue for Cooper Companies as of December 14, 2017 is $2.14B.
|Medical||Medical & Dental Supplies||$11.006B||$2.139B|
|The Cooper Companies, Inc. (Cooper) is a public holding company traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia. Cooper operates through two business units, CooperVision (CVI) and CooperSurgical (CSI). CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.|